Marino Stram & Associates’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Marino Stram & Associates’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-621	Closed	-$10K	–	503
2019 Q1	$10K	Hold	621	–	–	0.01%	304
2018 Q4	$10K	Hold	621	–	–	0.01%	279
2018 Q3	$13K	Hold	621	–	–	0.01%	281
2018 Q2	$15K	Hold	621	–	–	0.01%	269
2018 Q1	$11K	Hold	621	–	–	0.01%	305
2017 Q4	$12K	Buy	+621	New	+$9.34K	0.01%	296

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Marino Stram & Associates's TEVA Position: Q2 2019 in Review

Marino Stram & Associates sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2019, closing a stake of 621 shares — an estimated $10K sold.

Marino Stram & Associates first reported a position in TEVA in Q4 2017 and held it in 6 quarters. The position peaked at $15K in Q2 2018. 452 funds tracked by Wall St. Rank hold TEVA as of Q2 2019.

Marino Stram & Associates reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2019 after selling out during the quarter.
Marino Stram & Associates sold 621 Teva Pharmaceutical Industries Limited shares in Q2 2019, an estimated $10K.
Marino Stram & Associates first reported a position in Teva Pharmaceutical Industries Limited in Q4 2017 and held it in 6 quarters.
Marino Stram & Associates's Teva Pharmaceutical Industries Limited position peaked at $15K in Q2 2018.
452 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2019.

Based on Marino Stram & Associates's 13F filing for Q2 2019, filed 19 Jul 2019.